Omnicell

SEPTEMBER 5, 2022

Terri Albarano, PharmD Director, Autonomous Pharmacy, Omnicell Sterile compounding safety is one of the biggest challenges for the pharmacy supply chain. Health systems are expected to compound IV preparations with increasingly complex regulations, rising drug costs, and supply disruptions. Injectable medications cause 1.2

Sterile Compounds 52

Sterile Compounds Compounding Omnicell 52

Omnicell

SEPTEMBER 5, 2022

David Webster Director of Acute Care Pharmacy Operations, University of Rochester Medical Center Sterile compounding is one of the most high risk, high cost areas of medication management. Manual compounding is fraught with error, studies indicating 1 in 10 IVs are not prepared according to guidelines.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell 52

Omnicell

SEPTEMBER 5, 2022

Joy Somogyi Senior Director of Product Marketing and Development, Omnicell With two million people suffering from opioid addiction and 115 people dying from an opioid overdose every day in the U.S., the opioid crisis is one of the major challenges healthcare is facing, specifically for pharmacies currently managing medication diversion.

Omnicell 52

Omnicell Controlled Substances Hospitals Documentation 52

Omnicell

JANUARY 10, 2023

Denise Cox SVP, Chief Customer Officer, North America, Omnicell Women currently hold more than 75% of all healthcare jobs in the United States, versus just 8% in the 1960s. Implications for women of color are even worse, with only 5% of C-suite positions held by minority women.

Omnicell 52

Omnicell Compounding Communication Hospitals 52